The Obama Administration opposes a proposed independent probe by the Inspector General of the anthrax-laced letter attacks, arguing that it would "undermine public confidence” in a Federal Bureau of Investigation probe of the attacks “and unfairly cast doubt on its conclusions.”
Last Chance to Send Comments RE: Proposed Reclassification of ECTdevices
Vaccines against cervical cancer and shingles “don’t fit into the whole public health spirit of outbreak prevention.”
Dr. Joshua Sharfstein, the FDA’s principal deputy commissioner, acknowledged: “The message here is that there were problems with the integrity of F.D.A.’s decision-making process that have solutions.”
"How can they call this America, the land of the free?" she asked. "Where are my parental rights?"
Two high ranking FDA officials’ conflicts of interest have led one to resign, the other is under investigation by the Inspector General of the Department of Health and Human Services:
Essentially PhRMA won the right to continue bilking the beleaguered American taxpayer–a concession won under the Bush Administration which prohibited Medicare to negotiate prescription drug prices.
…an aggressive campaign to vaccinate against the swine flu–EVEN BEFORE THE VACCINE’S SAFETY HAS BEEN TESTED, or the safety of the vaccine adjuvants have been tested.
Forbes Magazine reports "How one company turned a rejection into a thumbs up, and what it could mean for the drug industry as a whole."
The FDA is sliding rapidly down the slippery slope, abandoning widely accepted, international ethical research standards articulated in the internationally accepted, Declaration of Helsinki–to facilitate commercial medical experiments.
FDA officials who continue to run its powerful center for drug evaluation (CDER) have once again shown bad faith by appointing financially compromised doctors to the Psychopharmacologic Drugs Advisory Committee (PDAC) advisory panel.
Another research scam uncovered by the GAO sting involved a "bogus IRB with a pet dog as its CEO."
